Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378(9785):57–72.
Article
PubMed
Google Scholar
The World Health Organizations. Global tuberculosis report 2018. Available at: www.aidsdatahub.org/global-tuberculosis-report-2018-who-2018.
Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2014;44(2):435–46.
Article
PubMed
Google Scholar
Ford N, Matteelli A, Shubber Z, Hermans S, Meintjes G, Grinsztejn B, et al. TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis. J Int AIDS Soc. 2016;19(1):20714.
Article
PubMed
PubMed Central
Google Scholar
O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475–527.
Article
CAS
PubMed
Google Scholar
Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010;375(9729):1920–37.
Article
CAS
PubMed
Google Scholar
Zhao Y, Yang X, Zhang X, Yu Q, Zhao P, Wang J, et al. IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring. Tuberculosis. 2018;111:45–53.
Article
CAS
PubMed
Google Scholar
Connell TG, Tebruegge M, Ritz N, Bryant P, Curtis N. The potential danger of a solely interferon-gamma release assay-based approach to testing for latent mycobacterium tuberculosis infection in children. Thorax. 2011;66(3):263–4.
Article
CAS
PubMed
Google Scholar
Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D, Klein NJ, et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J. 2009;28(8):669–73.
Article
PubMed
Google Scholar
Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, Peri G, et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in mycobacterium tuberculosis infection. Microbes Infect. 2005;7(1):1–8.
Article
CAS
PubMed
Google Scholar
Qiu X, Tang Y, Yue Y, Zeng Y, Li W, Qu Y, et al. Accuracy of interferon-γ-induced protein 10 for diagnosing latent tuberculosis infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2019;25(6):667–72.
Article
CAS
PubMed
Google Scholar
Aabye MG, Latorre I, Diaz J, Maldonado J, Mialdea I, Eugen-Olsen J, et al. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper. Eur Respir J. 2013;42(2):495–503.
Article
CAS
PubMed
PubMed Central
Google Scholar
Blauenfeldt T, Wagner D, Aabye M, Heyckendorf J, Lange B, Lange C, et al. Thermostability of IFN-gamma and IP-10 release assays for latent infection with mycobacterium tuberculosis: a TBnet study. Tuberculosis. 2016;98:7–12.
Article
CAS
PubMed
Google Scholar
Jacobs R, Malherbe S, Loxton AG, Stanley K, van der Spuy G, Walzl G, et al. Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response. Oncotarget. 2016;7(36):57581–92.
Article
PubMed
PubMed Central
Google Scholar
Lee K, Chung W, Jung Y, Kim Y, Park J, Sheen S, et al. CXCR3 ligands as clinical markers for pulmonary tuberculosis. Int J Tuberc Lung Dis. 2015;19(2):191–9.
Article
CAS
PubMed
Google Scholar
Azab NY, Elmahallawy I, Sharara G, Abdel-Atti E. The utility of the interferon gamma-inducible protein-10 (IP-10) level in bronchoalveolar lavage and blood in the diagnosis of tuberculosis. Egypt J Chest Dis Tuberc. 2013;62:629–34.
Article
Google Scholar
Wang X, Jiang J, Cao Z, Yang B, Zhang J, Cheng X. Diagnostic performance of multiplex cytokine and chemokine assay for tuberculosis. Tuberculosis. 2012;92(6):513–20.
Article
CAS
PubMed
Google Scholar
Hong JY, Jung GS, Kim H, Kim YM, Lee HJ, Cho S-N, et al. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis. Int J Infect Dis. 2012;16(12):E855–E9.
Article
CAS
PubMed
Google Scholar
Syed Ahamed Kabeer B, Raman B, Thomas A, Perumal V, Raja A. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One. 2010;5(2):e9051.
Article
PubMed
PubMed Central
CAS
Google Scholar
Luo J, Zhang M, Yan B, Li F, Guan S, Chang K, et al. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages of mycobacterium tuberculosis infection. J Infect. 2018;78(4):281–91.
Article
PubMed
Google Scholar
La Manna MP, Orlando V, Li Donni P, Sireci G, Di Carlo P, Cascio A, et al. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease. PLoS One. 2018;13(3):e0192664.
Article
PubMed
PubMed Central
CAS
Google Scholar
Balcells ME, Ruiz-Tagle C, Tiznado C, Garcia P, Naves R. Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection. Tuberculosis. 2018;112:110–9.
Article
CAS
PubMed
Google Scholar
Nonghanphithak D, Reechaipichitkul W, Namwat W, Naranbhai V, Faksri K. Chemokines additional to IFN-gamma can be used to differentiate among mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype. Tuberculosis. 2017;105:28–34.
Article
CAS
PubMed
Google Scholar
Biraro IA, Kimuda S, Egesa M, Cose S, Webb EL, Joloba M, et al. The use of interferon gamma inducible protein 10 as a potential biomarker in the diagnosis of latent tuberculosis infection in Uganda. PLoS One. 2016;11(1):e0146098.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, et al. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy. J Infect. 2015;70(4):381–91.
Article
CAS
PubMed
Google Scholar
Petrone L, Cannas A, Aloi F, Nsubuga M, Sserumkuma J, Nazziwa RA, et al. Blood or urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children. Biomed Res Int. 2015;2015:589471.
Article
PubMed
PubMed Central
Google Scholar
Latorre I, Diaz J, Mialdea I, Serra-Vidal M, Altet N, Prat C, et al. IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children. J Inf Secur. 2014;69(6):590–9.
CAS
Google Scholar
Wang S, Diao N, Lu C, Wu J, Gao Y, Chen J, et al. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PLoS One. 2012;7(12):e51338.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jeong YH, Hur Y-G, Lee H, Kim S, Cho J-E, Chang J, et al. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production. J Clin Microbiol. 2015;53(2):504–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388–96.
Article
PubMed
Google Scholar
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.
Article
PubMed
Google Scholar
Macaskill P, Gatsonis C, Deeks J, Harbord R, Takwoingi Y. Analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C, editors. Cochrane handbook for systematic reviews of diagnostic test accuracy; 2010.
Google Scholar
Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20(19):2865–84.
Article
CAS
PubMed
Google Scholar
Harbord RM, Whiting P. Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J. 2009;9:211–29.
Article
Google Scholar
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
Article
PubMed
Google Scholar
Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882–93.
Article
PubMed
Google Scholar
Jenkins HE, Yuen CM, Rodriguez CA, Nathavitharana RR, McLaughlin MM, Donald P, et al. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(3):285–95.
Article
PubMed
Google Scholar
Holm LL, Rose MV, Kimaro G, Bygbjerg IC, Mfinanga SG, Ravn P, et al. A comparison of interferon-gamma and IP-10 for the diagnosis of tuberculosis. Pediatrics. 2014;134(6):e1568–75.
Article
PubMed
Google Scholar
Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's new end TB strategy. Lancet. 2015;385(9979):1799–801.
Article
PubMed
Google Scholar
Guo SJ, Jia LQ, Hu QJ, Long HY, Pang CS, Wen FQ. Diagnostic accuracy of interferon gamma-induced protein 10 for tuberculosis: a meta-analysis. Int J Clin Exp Med. 2014;7(1):93–100.
PubMed
PubMed Central
Google Scholar
Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J. 2008;32(6):1607–15.
Article
CAS
PubMed
Google Scholar
Ruhwald M, Aabye MG, Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn. 2012;12(2):175–87.
Article
CAS
PubMed
Google Scholar
Mandalakas AM, Kirchner HL, Walzl G, Gie RP, Schaaf HS, Cotton MF, et al. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting. Am J Respir Crit Care Med. 2015;191(7):820–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vanini V, Petruccioli E, Gioia C, Cuzzi G, Orchi N, Rianda A, et al. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect. 2012;65(1):49–59.
Article
PubMed
Google Scholar
Aabye MG, Ruhwald M, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Faurholt-Jepsen D, et al. Potential of interferon-gamma-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J. 2010;36:1488–90.
Article
CAS
PubMed
Google Scholar